Alembic Pharmaceuticals
BSE 533573
3 stories, newest first.
- Step-down wholly owned subsidiary Alvesta Pharmaceuticals FZCO incorporated in Dubai, UAE
- USFDA final approval received for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%
- Alembic Pharmaceuticals Ltd shareholder sells 0.07% stake, holding falls to 2.97%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.